1. Home
  2. INUV vs GRDX Comparison

INUV vs GRDX Comparison

Compare INUV & GRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inuvo Inc.

INUV

Inuvo Inc.

HOLD

Current Price

$0.96

Market Cap

24.2M

ML Signal

HOLD

Logo GridAI Technologies Corp.

GRDX

GridAI Technologies Corp.

N/A

Current Price

$3.10

Market Cap

28.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INUV
GRDX
Founded
N/A
N/A
Country
United States
United Kingdom
Employees
N/A
2
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.2M
28.6M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
INUV
GRDX
Price
$0.96
$3.10
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
293.8K
49.4K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
50.00
N/A
EPS
0.13
N/A
Revenue
$86,209,305.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$12.89
N/A
P/E Ratio
$8.00
N/A
Revenue Growth
2.88
N/A
52 Week Low
$0.95
$1.87
52 Week High
$5.63
$6.93

Technical Indicators

Market Signals
Indicator
INUV
GRDX
Relative Strength Index (RSI) 35.19 34.12
Support Level N/A $2.01
Resistance Level $1.37 $3.65
Average True Range (ATR) 0.13 0.42
MACD -0.00 -0.09
Stochastic Oscillator 6.05 15.38

Price Performance

Historical Comparison
INUV
GRDX

About INUV Inuvo Inc.

Inuvo Inc is an advertising technology and services company that has developed and commercialized large language generative artificial intelligence (AI) for modeling media audiences. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

About GRDX GridAI Technologies Corp.

GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

Share on Social Networks: